Auvi-Q (epinephrine) NDC 71872-7333

Product information

Brand name (proprietary)

Auvi-Q

Generic name (nonproprietary)

epinephrine

Active ingredients

Epinephrine — .15 mg/.15mL

Dosage form

Injection, Solution

Route

Intramuscular

Labeler

Medical Purchasing Solutions, LLC

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 201739

Marketing start

Nov 15, 2012

Listing expires

Dec 31, 2026

Other FDA classes

Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Catecholamines (Chemical structure)

Identifiers

Product ID 71872-7333_296a89b9-bd35-76d9-e063-6294a90a101dSPL ID 296a89b9-bd35-76d9-e063-6294a90a101dSPL set ID 296a9023-b5c6-6102-e063-6294a90af87eRxCUI 1305268, 1870232UNII YKH834O4BH

Pharmacologic class

Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J0171 — Injection, adrenalin, epinephrine, 0.1 mg

Billing unit: 0.1 mg. Units on the claim = dose given ÷ 0.1 mg.

Applies when epinephrine is administered in a clinical setting. Auto-injectors dispensed to patients are billed by NDC through a pharmacy benefit.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N471872733301 followed by a unit qualifier and the quantity Copy

Package 71872-7333-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under NDA 201739

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.